학술논문
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression
Document Type
Article
Author
Source
In Urology 2001 58(2):146-150
Subject
Language
ISSN
0090-4295